CAD News Briefs

prescription pad

Two Therapeutic Approaches to CAD Each Have Their Own Benefits and Drawbacks

Therapies targeting the pathogenic B-cell clone and the classical complement pathway have emerged as a new hope for treating cold agglutinin disease (CAD), allowing clinicians to choose between treatment approaches. In a new review article published in Transfusion Medicine Reviews, Sigbjørn Berentsen and Geir E. Tjønnfjord highlighted important differences between the B-cell-directed combination of bendamustine…

blood tranfusion

CAD Not Responsive to Some Measures Used in Warm Hemolytic Anemia

Although emergency and general measures for warm antibody autoimmune hemolytic anemia (AIHA) and AIHA due to cold agglutinin disease (CAD) are similar, specific therapies available for warm AIHA are not effective for CAD. Therefore, the preliminary identification of the type of antibody involved in each case is particularly relevant, according to a recently published article in Clinical…


Autoimmune Hemolytic Anemia Linked With High Mortality in the ICU

Autoimmune hemolytic anemia (AIHA), one type of which is cold agglutinin disease (CAD), is usually considered a benign hematological disease. However, it is associated with high mortality in the intensive care unit (ICU) regardless of age and treatment, according to a recently published study in the American Journal of Hematology. According to several studies, AIHA has…

NORD banners

Rare Disease Patients and Advocate to Headline NORD Conference in October

Two rare disease patients and a rare disease advocate will be the keynote speakers at the National Organization for Rare Disorders (NORD) 2022 annual rare disease conference, being held at the Marriott Marquis in Washington, DC, on October 17 and 18, 2022.   NORD announced the keynote speakers as Brittany Clayborne, MS, PsyD, a post-transplant…

coronavirus cells

The First Report of an HbE Heterozygous Patient With CAD and COVID-19 Infection

A rare occurrence of cold agglutinin disease (CAD) that accompanied a COVID-19 infection has been reported in a woman with the hemoglobin E (HbE) heterozygous phenotype. Findings from this case study were recently published in the Annals of Clinical Case Reports. Few case reports of autoimmune hemolytic anemia (AIHA), of which CAD is a type,…

COVID19 virus

High Cold Agglutinin Titers Reported in Two COVID-19 Case Reports

Two patients with COVID-19 were found to have high cold agglutinin (CA) titers without presenting with hemolytic anemia or thrombosis commonly associated with cold agglutinin disease (CAD), according to a recently published article in the Journal of Clinical Laboratory Analysis. “Several studies of (cold agglutinin syndrome) associated with coronavirus disease 2019 (COVID-19) reported hemolytic anemia and…

woman typing on computer

Patients With CAD Report Pervasive Fatigue, Worsening Symptoms

Patients with cold agglutinin disease (CAD) may experience a recurrent decline in their quality of life, according to a study recently published in JMIR Formative Research. The study “highlights the importance and type of fatigue, seriousness of the disease as perceived by patients, impact of CAD even when no symptoms are experienced, and importance of…

Vials With the Covid-19 Vaccine and Syringes are Displayed On a Tray at the Corona Vaccination Center

COVID-19 Vaccination Linked With Detection of CAD

Researchers revealed that the global vaccination against COVID-19 has led to the detection of autoimmune hematologic disorders such as cold agglutinin disease (CAD), as published in Vaccines. They noted that while these serious adverse events are rare, they can be life-threatening, and therefore rapid and accurate diagnoses are essential. “Vaccines against SARS-CoV-2, like other ones,…

Cell, Gene Therapy Breakthroughs Outpacing Healthcare System, Experts Say

The US healthcare system cannot keep up with the rapidly advancing field of gene therapy, experts who spoke at the 2022 World Orphan Drug Congress said.

Next post in WODC 2022